• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; 1%  SODIUM HYALURONATE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. EUFLEXXA; 1%  SODIUM HYALURONATE Back to Search Results
Catalog Number 6301182010
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Pain (1994); Swelling/ Edema (4577)
Event Type  Injury  
Event Description
Breast/nipple bleeding since then [breast haemorrhage].Localized swelling [swelling].Pain to knee [arthralgia].Case narrative: this serious spontaneous case received from a consumer in united states.This report concerns a 70-year-old female who experienced breast/nipple bleeding, localized swelling, and pain to the knee during treatment with euflexxa (sodium hyaluronate) solution for injection, unknown route, concentration, and dose, for an unknown indication from 29-dec-2022 to an unknown stop date.The consumer received her first euflexxa injection on 29-dec-2022 and experienced breast/nipple bleeding since then (beginning on an unspecified date).Additionally, she experienced "all of the local side effects too", which was further explained as localized swelling and pain to the knee.No further information was provided.The breast/nipple bleeding since then was medically significant.Action taken with euflexxa was unknown.On an unknown date, the outcome of breast/nipple bleeding since then was not recovered, the outcome of localized swelling was unknown, the outcome of pain to knee was unknown.No concomitant medication was reported.The event breast/nipple bleeding since then was reported as serious.The events localized swelling, pain to knee were reported as non-serious.At the time of reporting the case outcome was unknown.Sender comment: very limited and important information has not been reported for this case including the patient's medical history, laboratory findings, concomitant medication, product indication, therapy dates, route of administration; furthermore, based on the known safety profile, when used according to label, it is considered highly unlikely that euflexxa caused the patient's breast bleeding.Overall listedness (core label) is unlisted.Reporter causality: related company causality: not related (breast bleeding) other case numbers: internal # - others = fmc-case-000718.Internal # - others = fmc-event-000209.This ae occurred in united states and concerns the medical device euflexxa.Please report to your local health authority if required by local law.This ae is not reportable in eu because it does not meet the definition of a medical device incident according to the requirements of the medical device directive/ because it did not occur in a eu + efta country and did not result in a corrective action by the manufacturer.No corrective action was done by the manufacturer or requested by regulators.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUFLEXXA
Type of Device
1%  SODIUM HYALURONATE
Manufacturer (Section D)
BIO-TECHNOLOGY GENERAL (ISRAEL) LTD.
pob 571, be'er tuvia industria
l zone
kiryat malachi 83104 02
IS  8310402
Manufacturer (Section G)
FERRINGPH
100 interpace parkway
parsippany 07054
Manufacturer Contact
pob 571, be'er tuvia industria
l zone
kiryat malachi 83104-02
2542274192
MDR Report Key16215565
MDR Text Key307818379
Report Number3000164186-2023-00004
Device Sequence Number1
Product Code MOZ
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P010029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 01/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number6301182010
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received01/20/2023
Is the Device Single Use? Yes
Type of Device Usage A
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age70 YR
Patient SexFemale
-
-